Ghrelin Levels in Children With Poor Growth

Status Completed

Clinical Trial Summary

The investigators hypothesize that low serum ghrelin levels may characterize a group of patients with poor weight gain and/or linear growth who do not have any other identified cause for growth failure. These patients may present with a variety of complaints and are often evaluated by both pediatric endocrinologists and pediatric gastroenterologists. The investigators hypothesize that ghrelin has a physiologically important role in linear growth and that chronic diseases of the gastrointestinal system, such as H. Pylori infection or celiac disease, may alter serum ghrelin levels in children. Low ghrelin levels may be a factor leading to poor growth, potentially by altering growth hormone secretion and/or by decreasing appetite. By measuring ghrelin levels in children with short stature and in children with gastrointestinal disease, the investigators will further elucidate the possible physiologic role of ghrelin in childhood growth and how it may be altered in conditions causing short stature and in certain gastrointestinal diseases.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01070173
Study type	Observational
Source	Tripler Army Medical Center
Contact
Status	Completed
Phase	N/A
Start date	January 2008
Completion date	September 2010

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06382155` - A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature	Phase 2
Recruiting	`NCT05894876` - A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature
Completed	`NCT01246219` - Short Stature Related Distress	Phase 4
Completed	`NCT00965484` - Genotropin Study Assessing Use of Injection Pen	Phase 3
Completed	`NCT00710307` - Epidemiology Study on Insulin-like Growth Factor-1 in Children With Idiopathic Short Stature (EPIGROW Study)
Completed	`NCT01504802` - Pharmacodynamics of CNP During Growth Hormone Treatment	N/A
Completed	`NCT01248416` - Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature	Phase 3
Completed	`NCT00488124` - Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin	Phase 2
Withdrawn	`NCT01438801` - Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth Hormone Treatment (PRED-IGF)	Phase 4
Recruiting	`NCT06309979` - A Study to Assess Growth in Children With Idiopathic Short Stature
Terminated	`NCT00121875` - Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature	Phase 4
Not yet recruiting	`NCT05858606` - Multidisciplinary Evaluation and a Genome-wide Analysis in a Cohort of Idiopathic Short Stature Patients	N/A
Active, not recruiting	`NCT04020913` - Skeletal Muscle Effects of GH in Boys
Completed	`NCT01401244` - Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers	Phase 1
Recruiting	`NCT02973061` - The Impact of the Use of Recombinant Human Growth Hormone on ADHD Characteristics in Children and Adolescents
Completed	`NCT01778023` - Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature	Phase 3
Recruiting	`NCT01604395` - Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children
Active, not recruiting	`NCT00840944` - A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height	Phase 4
Completed	`NCT01543867` - Safety and Efficacy of Long-term Somatropin Treatment in Children	N/A
Recruiting	`NCT04798690` - Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature